BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1605205)

  • 1. Validation of linkage-based DNA-diagnosis of fragile X gene carriers with the CGG repeat probe.
    van Oost BA; Smits AP; Dreesen JC; van den Ouweland AM; Oostra BA
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):320-7. PubMed ID: 1605205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental origin of the fra(X) gene is a major determinant of the cytogenetic expression and the CGG repeat length in female carriers.
    Smits A; Smeets D; Dreesen J; Hamel B; de Haan A; van Oost B
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):261-7. PubMed ID: 1605199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length.
    Smits A; Smeets D; Hamel B; Dreesen J; de Haan A; van Oost B
    Am J Med Genet; 1994 Jul; 51(4):497-500. PubMed ID: 7943027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On some technical aspects of direct DNA diagnosis of the fragile X syndrome.
    Rousseau F; Heitz D; Biancalana V; Oberlé I; Mandel JL
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):197-207. PubMed ID: 1351361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of the use of flanking DNA markers for fra(X) syndrome carrier detection and prenatal diagnosis.
    Forster-Gibson CJ; Mulligan LM; Simpson NE; White BN; Holden JJ
    Am J Med Genet; 1986; 23(1-2):665-83. PubMed ID: 3006491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragile X syndrome: no evidence for any recent mutations.
    Smits AP; Dreesen JC; Post JG; Smeets DF; de Die-Smulders C; Spaans-van der Bijl T; Govaerts LC; Warren ST; Oostra BA; van Oost BA
    J Med Genet; 1993 Feb; 30(2):94-6. PubMed ID: 8445628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent small amplifications in the FMR-1 gene in fra(X) families: limits to the diagnosis of 'premutations'.
    Macpherson JN; Nelson DL; Jacobs PA
    J Med Genet; 1992 Nov; 29(11):802-6. PubMed ID: 1453431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragenic probe used for diagnostics in fragile X families.
    Verkerk AJ; deVries BB; Niermeijer MF; Fu YH; Nelson DL; Warren ST; Majoor-Krakauer DF; Halley DJ; Oostra BA
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):192-6. PubMed ID: 1605192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular studies of the fragile X syndrome.
    Knight SJ; Hirst MC; Roche A; Christodoulou Z; Huson SM; Winter R; Fitchett M; McKinley MJ; Lindenbaum RH; Nakahori Y
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):217-23. PubMed ID: 1605194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile X syndrome: discordant levels of CGG repeat mosaicism in two brothers.
    Mueller OT; Hartsfield JK; Amar MJ; Gallardo LA; Kousseff BG
    Am J Med Genet; 1995 Aug; 60(4):302-6. PubMed ID: 7485265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families.
    Milà M; Kruyer H; Glover G; Sánchez A; Carbonell P; Castellví-Bell S; Volpini V; Rossell J; Gabarrón J; López I
    Hum Genet; 1994 Oct; 94(4):395-400. PubMed ID: 7927336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A genetic and molecular study of 85 families affected with the fragile X syndrome].
    Milà Recasens M; Sánchez Díaz A; Glover López G; Castellví Bel S; Carbonell Meseguer P; Kruyer H; Ballesta Martínez F; Estivill Pallejà X
    An Esp Pediatr; 1996 Mar; 44(3):250-6. PubMed ID: 8830601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unstable DNA sequence and methylation in fragile X syndrome].
    Fu SD; Shen Y; Fan Y
    Zhonghua Yi Xue Za Zhi; 1994 Oct; 74(10):611-4, 646-7. PubMed ID: 7842338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-based genetic testing in fifty fragile X families.
    Murphy PD; Watson MS; Shapiro LR; Wilmot PL; Breg WR
    Am J Med Genet; 1991; 38(2-3):305-10. PubMed ID: 1673302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for genetic heterogeneity in the fragile X syndrome.
    Brown WT; Jenkins EC; Gross AC; Chan CB; Krawczun MS; Duncan CJ; Sklower SL; Fisch GS
    Hum Genet; 1987 Apr; 75(4):311-21. PubMed ID: 2883105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier detection of the fragile X syndrome with flanking RFLP markers and linkage analysis.
    Väisänen ML; Kähkönen M; Leisti J
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):307-11. PubMed ID: 1351364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of fragile X syndrome: results from parallel molecular and cytogenetic studies.
    Murphy PD; Wilmot PL; Shapiro LR
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):181-6. PubMed ID: 1605190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of expansion of CGG repeats and X-inactivation with expression of fra(X)(q27.3) in heterozygotes.
    Mingroni-Netto RC; Fernandes JG; Vianna-Morgante AM
    Am J Med Genet; 1994 Jul; 51(4):443-6. PubMed ID: 7943014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
    Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E
    Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for reliable prenatal detection of normal male carriers of the fragile X syndrome.
    Halley D; Van Den Ouweland A; Deelen W; Verma I; Oostra B
    Am J Med Genet; 1994 Jul; 51(4):471-3. PubMed ID: 7943022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.